Tandem Diabetes Care Inc (TNDM) 15.43 $TNDM
Tandem Diabetes Care Reports First Quarter 2014 Financial Results
PR Newswire - Tue May 06, 3:15PM CDT
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter ended March 31, 2014.
Tandem Diabetes Care Announces Schedule Change for Deutsche Bank 39th Annual Health Care Conference Presentation
GlobeNewswire - Fri May 02, 3:30PM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim(R) Insulin Pump, today announced a schedule change for its presentation at the Deutsche Bank 39th Annual Health Care Conference at the InterContinental Boston Hotel in Boston, Massachusetts. Kim Blickenstaff, president and CEO, will now be presenting at 11:20am Eastern Time on Thursday, May 8, 2014.
Tandem Diabetes Care Announces Upcoming Conference Presentations
GlobeNewswire - Mon Apr 28, 7:01AM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim(R) Insulin Pump, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences:
Tandem Diabetes Care Schedules First Quarter 2014 Earnings Press Release and Conference Call
GlobeNewswire - Wed Apr 23, 7:01AM CDT
Tandem Diabetes Care, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim Insulin Pump, plans to release its first quarter 2014 results after the financial markets close on Tuesday, May 6, 2014. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its first quarter 2014 financial and operating results.
1 Stock Helping Revolutionize Diabetes Monitoring
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 16, 10:41AM CDT
More than 365 million people have diabetes worldwide and estimates suggest that the number of diabetics will grow to more than half a billion people around the globe by 2030. As a result, the market for new, innovative therapies that improve how...
Tandem Diabetes Care and Capital Royalty Amend and Restate Term Loan Facility
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM) and Capital Royalty Partners II, L.P. and its affiliate funds ("Capital Royalty"
today announced that they have amended and restated the term loan facility under which the Company borrowed $30 million in January 2013. This amendment extends the maturity date under the Company's term loan facility from December 31, 2017 to March 31, 2020. Under the terms of the restated agreement, the interest rate was reduced from 14.0 percent to 11.5 percent, and the interest only payment period was extended through March 31, 2018. In addition, the Company has entered into a second loan agreement with Capital Royalty and Parallel Investment Opportunities Partners II L.P. that provides the Company with the option to access up to an additional $30 million on or before March 31, 2015 at the same interest rate and on the same key terms.
2 Unusual-Volume Stocks in Breakout Territory
at The Street - Mon Mar 10, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Thu Mar 06, 3:15PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter and year ended December 31, 2013.
Data Presented at ATTD 2014 Suggest t:slim® Insulin Pump Faster to Train with Fewer Use Errors than Competition
PR Newswire - Thu Feb 06, 3:30AM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today presented the results of a research study that demonstrated faster training times and fewer errors when using the t:slim Pump versus a leading insulin pump. These data were presented at the 7th Annual Advanced Technologies and Treatments for Diabetes (ATTD) International Conference in Vienna, Austria.
Tandem Diabetes Care to Present at Leerink Global Healthcare Conference
PR Newswire - Wed Jan 29, 7:00AM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Leerink Global Healthcare Conference in New York, NY. The presentation will take place on Wednesday, February 12, 2014 at 11:05am Eastern Time (8:05am Pacific Time).
Tandem Diabetes Care Expands Voluntary Recall for Select Lots of Insulin Cartridges Used with t:slim Insulin Pump
PR Newswire - Mon Jan 20, 4:10PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), or Tandem, today announced that it is expanding a voluntary recall of specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking. This could potentially result in the device delivering too much or too little insulin, which can lead to a serious adverse event.
Tandem Diabetes Care Initiates Voluntary Recall for Specific Lots of Insulin Cartridges Used with t:slim Insulin Pump
PR Newswire - Fri Jan 10, 3:45PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it is initiating a voluntary recall of specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking. The cause of the recall was identified during Tandem's internal product testing, and has not been associated with any complaints or adverse events reported by customers. However, a cartridge leak could potentially result in the device delivering too much or too little insulin, which can lead to a serious adverse event.
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch
PR Newswire - Wed Dec 25, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), InterMune Inc. (NASDAQ: ITMN), Tandem Diabetes Care Inc (NASDAQ: TNDM), Nektar Therapeutics (NASDAQ: NKTR), and Greatbatch, Inc. (NYSE: GB). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Tandem Diabetes Care Added to Russell 2000® and Russell 3000® Indexes
PR Newswire - Fri Dec 20, 7:00PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that the company was added to the Russell 2000® and Russell 3000® Indexes following reconstitution of Russell Investment Group's family of US indexes after market close on December 20, 2013.
Tandem Diabetes Care Announces Closing of Initial Public Offering
PR Newswire - Tue Nov 19, 3:30PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the closing of its initial public offering of 9,200,000 shares of common stock at a price of $15.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,200,000 shares. All of the shares in the offering were offered by Tandem. Tandem's common stock is listed on the NASDAQ Global Market under the ticker symbol "TNDM."
Stocks Show Resilience Again; Focus On Yellen, Not Cisco
at Investor's Business Daily - Thu Nov 14, 12:18PM CST
Stocks were turning in another solid performance Thursday, undeterred by sluggish earnings from Cisco Systems (CSCO) late Wednesday. Cisco's earnings-related sell-off was offset by testimony from Federal Reserve Vice Chairwoman Janet Yellen at her...
NASDAQ Welcomes Tandem Diabetes Care (NASDAQ: TNDM) to The NASDAQ Stock Market
GlobeNewswire - Thu Nov 14, 11:42AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that trading of Tandem Diabetes Care, Inc. (Nasdaq:TNDM), a leading provider of insulin pump therapy, commenced on The NASDAQ Stock Market on November 14, 2013.
Tandem Diabetes Care shares jump in market debut
AP - Thu Nov 14, 10:27AM CST
SAN DIEGO (AP) — Shares of Tandem Diabetes Care Inc. soared in their first day of trading as a public company.
Tandem Diabetes Care Reports First Quarter 2014 Financial Results
PR Newswire - Tue May 06, 3:15PM CDT
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter ended March 31, 2014.
Tandem Diabetes Care Announces Schedule Change for Deutsche Bank 39th Annual Health Care Conference Presentation
GlobeNewswire - Fri May 02, 3:30PM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim(R) Insulin Pump, today announced a schedule change for its presentation at the Deutsche Bank 39th Annual Health Care Conference at the InterContinental Boston Hotel in Boston, Massachusetts. Kim Blickenstaff, president and CEO, will now be presenting at 11:20am Eastern Time on Thursday, May 8, 2014.
Tandem Diabetes Care Announces Upcoming Conference Presentations
GlobeNewswire - Mon Apr 28, 7:01AM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim(R) Insulin Pump, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences:
Tandem Diabetes Care Schedules First Quarter 2014 Earnings Press Release and Conference Call
GlobeNewswire - Wed Apr 23, 7:01AM CDT
Tandem Diabetes Care, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim Insulin Pump, plans to release its first quarter 2014 results after the financial markets close on Tuesday, May 6, 2014. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its first quarter 2014 financial and operating results.
1 Stock Helping Revolutionize Diabetes Monitoring
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 16, 10:41AM CDT
More than 365 million people have diabetes worldwide and estimates suggest that the number of diabetics will grow to more than half a billion people around the globe by 2030. As a result, the market for new, innovative therapies that improve how...
Tandem Diabetes Care and Capital Royalty Amend and Restate Term Loan Facility
GlobeNewswire - Wed Apr 09, 8:22AM CDT
Tandem Diabetes Care(R), Inc. (Nasdaq:TNDM) and Capital Royalty Partners II, L.P. and its affiliate funds ("Capital Royalty"
today announced that they have amended and restated the term loan facility under which the Company borrowed $30 million in January 2013. This amendment extends the maturity date under the Company's term loan facility from December 31, 2017 to March 31, 2020. Under the terms of the restated agreement, the interest rate was reduced from 14.0 percent to 11.5 percent, and the interest only payment period was extended through March 31, 2018. In addition, the Company has entered into a second loan agreement with Capital Royalty and Parallel Investment Opportunities Partners II L.P. that provides the Company with the option to access up to an additional $30 million on or before March 31, 2015 at the same interest rate and on the same key terms. 2 Unusual-Volume Stocks in Breakout Territory
at The Street - Mon Mar 10, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Thu Mar 06, 3:15PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter and year ended December 31, 2013.
Data Presented at ATTD 2014 Suggest t:slim® Insulin Pump Faster to Train with Fewer Use Errors than Competition
PR Newswire - Thu Feb 06, 3:30AM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today presented the results of a research study that demonstrated faster training times and fewer errors when using the t:slim Pump versus a leading insulin pump. These data were presented at the 7th Annual Advanced Technologies and Treatments for Diabetes (ATTD) International Conference in Vienna, Austria.
Tandem Diabetes Care to Present at Leerink Global Healthcare Conference
PR Newswire - Wed Jan 29, 7:00AM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Leerink Global Healthcare Conference in New York, NY. The presentation will take place on Wednesday, February 12, 2014 at 11:05am Eastern Time (8:05am Pacific Time).
Tandem Diabetes Care Expands Voluntary Recall for Select Lots of Insulin Cartridges Used with t:slim Insulin Pump
PR Newswire - Mon Jan 20, 4:10PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), or Tandem, today announced that it is expanding a voluntary recall of specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking. This could potentially result in the device delivering too much or too little insulin, which can lead to a serious adverse event.
Tandem Diabetes Care Initiates Voluntary Recall for Specific Lots of Insulin Cartridges Used with t:slim Insulin Pump
PR Newswire - Fri Jan 10, 3:45PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it is initiating a voluntary recall of specific lots of insulin cartridges that are used with the t:slim® Insulin Pump. The affected cartridges may be at risk for leaking. The cause of the recall was identified during Tandem's internal product testing, and has not been associated with any complaints or adverse events reported by customers. However, a cartridge leak could potentially result in the device delivering too much or too little insulin, which can lead to a serious adverse event.
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch
PR Newswire - Wed Dec 25, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), InterMune Inc. (NASDAQ: ITMN), Tandem Diabetes Care Inc (NASDAQ: TNDM), Nektar Therapeutics (NASDAQ: NKTR), and Greatbatch, Inc. (NYSE: GB). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Tandem Diabetes Care Added to Russell 2000® and Russell 3000® Indexes
PR Newswire - Fri Dec 20, 7:00PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that the company was added to the Russell 2000® and Russell 3000® Indexes following reconstitution of Russell Investment Group's family of US indexes after market close on December 20, 2013.
Tandem Diabetes Care Announces Closing of Initial Public Offering
PR Newswire - Tue Nov 19, 3:30PM CST
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the closing of its initial public offering of 9,200,000 shares of common stock at a price of $15.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,200,000 shares. All of the shares in the offering were offered by Tandem. Tandem's common stock is listed on the NASDAQ Global Market under the ticker symbol "TNDM."
Stocks Show Resilience Again; Focus On Yellen, Not Cisco
at Investor's Business Daily - Thu Nov 14, 12:18PM CST
Stocks were turning in another solid performance Thursday, undeterred by sluggish earnings from Cisco Systems (CSCO) late Wednesday. Cisco's earnings-related sell-off was offset by testimony from Federal Reserve Vice Chairwoman Janet Yellen at her...
NASDAQ Welcomes Tandem Diabetes Care (NASDAQ: TNDM) to The NASDAQ Stock Market
GlobeNewswire - Thu Nov 14, 11:42AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that trading of Tandem Diabetes Care, Inc. (Nasdaq:TNDM), a leading provider of insulin pump therapy, commenced on The NASDAQ Stock Market on November 14, 2013.
Tandem Diabetes Care shares jump in market debut
AP - Thu Nov 14, 10:27AM CST
SAN DIEGO (AP) — Shares of Tandem Diabetes Care Inc. soared in their first day of trading as a public company.
